Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study
Condition(s):Old Age; Debility; Renal Carcinoma MetastaticLast Updated:January 9, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Old Age; Debility; Renal Carcinoma MetastaticLast Updated:January 9, 2024Completed
Condition(s):Bladder Cancer; Kidney Tumor; Prostate CancerLast Updated:July 29, 2014Withdrawn
Condition(s):Kidney CancerLast Updated:November 18, 2023Active, not recruiting
Condition(s):Renal Cancer; Tumor, Solid; Kidney Cancer; Tumor; Tumor, Benign; Kidney NeoplasmsLast Updated:March 21, 2024Recruiting
Condition(s):Kidney Neoplasms; Carcinoma, Renal CellLast Updated:January 27, 2020Withdrawn
Condition(s):Childhood Renal Cell Carcinoma; Clear Cell Renal Cell Carcinoma; Clear Cell Sarcoma of the Kidney; Papillary Renal Cell Carcinoma; Rhabdoid Tumor of the Kidney; Stage I Renal Cell Cancer; Stage I Renal Wilms Tumor; Stage II Renal Cell Cancer; Stage II Renal Wilms Tumor; Stage III Renal Cell Cancer; Stage III Renal Wilms Tumor; Stage IV Renal Cell Cancer; Stage IV Renal Wilms TumorLast Updated:July 21, 2017Completed
Condition(s):Kidney CancerLast Updated:April 18, 2017Completed
Condition(s):Stage IV Kidney CancerLast Updated:September 29, 2017Terminated
Condition(s):Advanced Renal Cell CarcinomaLast Updated:May 13, 2013Completed
Condition(s):Melanoma; Lung Cancer; Renal CancerLast Updated:December 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.